| Dr Lisa Maxwell, MD | |
|
675 Coveglen Ct, Colorado Springs, CO 80906-6801 | |
| (706) 726-5472 | |
| Not Available |
| Full Name | Dr Lisa Maxwell |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 675 Coveglen Ct, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568438026 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01052947A (Indiana) | Secondary |
| 208600000X | Surgery | DR.0053436 (Colorado) | Primary |
| Entity Name | Acute Surgical And Trauma Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477660694 PECOS PAC ID: 7012950330 Enrollment ID: O20050608000172 |
News Archive
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
A new study explores the real-world efficacy of monoclonal antibodies against COVID-19 in averting severe disease.
Mucus is an essential protective layer of gel-like liquid composed largely of proteins called mucins throughout our airways. One of them, called MUC5B, is crucial for the innate defense against the various things we inhale.
Using a technique that silences genes promoting infection, researchers have developed a novel, topically-applied molecular microbicide capable of preventing HIV transmission.
According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.
› Verified 4 days ago
| Entity Name | Scl Health Medical Group - Denver Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083021083 PECOS PAC ID: 0840513552 Enrollment ID: O20150106000131 |
News Archive
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
A new study explores the real-world efficacy of monoclonal antibodies against COVID-19 in averting severe disease.
Mucus is an essential protective layer of gel-like liquid composed largely of proteins called mucins throughout our airways. One of them, called MUC5B, is crucial for the innate defense against the various things we inhale.
Using a technique that silences genes promoting infection, researchers have developed a novel, topically-applied molecular microbicide capable of preventing HIV transmission.
According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa Maxwell, MD 675 Coveglen Ct, Colorado Springs, CO 80906-6801 Ph: (706) 726-5472 | Dr Lisa Maxwell, MD 675 Coveglen Ct, Colorado Springs, CO 80906-6801 Ph: (706) 726-5472 |
News Archive
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
A new study explores the real-world efficacy of monoclonal antibodies against COVID-19 in averting severe disease.
Mucus is an essential protective layer of gel-like liquid composed largely of proteins called mucins throughout our airways. One of them, called MUC5B, is crucial for the innate defense against the various things we inhale.
Using a technique that silences genes promoting infection, researchers have developed a novel, topically-applied molecular microbicide capable of preventing HIV transmission.
According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.
› Verified 4 days ago
Dr. Larry D Dillon, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1715 N Weber St, Ste 330, Colorado Springs, CO 80907 Phone: 719-473-7400 Fax: 719-473-7408 | |
Khurram Ahmad Khan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1633 Medical Center Point, Colorado Springs, CO 80907 Phone: 719-475-9800 Fax: 719-473-5436 | |
Thomas J. Schroeppel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 E Boulder St, Suite 600, Colorado Springs, CO 80909 Phone: 719-364-6487 Fax: 719-364-6488 | |
Dr. Amilu Rothhammer, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1633 Medical Center Pt, Colorado Springs, CO 80907 Phone: 719-475-9800 | |
Dr. Lisa Lynn Schlitzkus, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 E Boulder St Ste 500, Colorado Springs, CO 80909 Phone: 719-364-6487 | |
Gregory Carlson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 E Boulder St, Suite 600, Colorado Springs, CO 80909 Phone: 719-365-6487 Fax: 719-364-6488 | |
Dr. John Lindley Frerichs, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 4925 N Nevada Ave, Room 416, Colorado Springs, CO 80918 Phone: 719-425-0933 |